GILEAD SCIENCES, INC. Q3 2025 Filing
Filed November 13, 2025
Portfolio Value
$1.8T
Holdings
9
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GLPGGALAPAGOS NV | 16,707,477 | $578.7B | 32.31% | |
| 2 | ACLXARCELLX INC | 6,720,803 | $551.8B | 30.80% | |
| 3 | RCUSARCUS BIOSCIENCES INC | 31,424,760 | $427.4B | 23.86% | |
| 4 | ASMBASSEMBLY BIOSCIENCES INC | 4,505,391 | $115.3B | 6.44% | |
| 5 | MRUSMERUS N V | 452,527 | $42.6B | 2.38% | |
| 6 | TNGXTANGO THERAPEUTICS INC | 4,854,443 | $40.8B | 2.28% | |
| 7 | KYTXKYVERNA THERAPEUTICS INC | 4,126,119 | $24.8B | 1.38% | |
| 8 | XLOXILIO THERAPEUTICS INC | 9,105,451 | $7.7B | 0.43% | |
| 9 | CYPHLEAP THERAPEUTICS INC | 5,319,148 | $2.4B | 0.13% |